CD8A and colorectal carcinoma: In early-stage CRC, infiltration of activated CD8+ T cells into peritumoral and precancerous tissues correlates with improved prognosis, whereas patients with stage I or II CRC who lack CD8+ T-cell infiltration face a markedly elevated risk of recurrence within 5 years [37].